Dechra Pharmaceuticals Share Price (DPH)

932.50 +2.50 (+0.27%) delayed: 8:37PM GMT
Bid price 932.50 Open price 930.00
Ask price 935.00 Prev close 932.50
High price 939.00 Spread 0.27%
Low price 923.66 Volume 454,429

Register now for FREE live Dechra Pharmaceuticals share prices, Dechra Pharmaceuticals stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Dechra Pharmaceuticals Level 2 Data, indepth research tools and investor commentary for Dechra Pharmaceuticals (DPH) and other London Stock Exchange equities.

Dechra Pharmaceuticals Share Price Chart

Advanced Charts >>

Register now for FREE Dechra Pharmaceuticals share price charts

Dechra Pharmaceuticals Share Price Information

Name Dechra Pharmaceuticals Epic DPH
Sector Pharmaceuticals & Biotechnology ISIN GB0009633180
Activites Dechra Pharmaceuticals plc is an international veterinary pharmaceutical business. Its expertise is in the development, manufacturing, distribution, sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. Index FTSE 250

Dechra Pharmaceuticals Key Numbers

Latest Share Price (p) 932.50 Net Gearing (%) 23.01
Market Capitalisation (£m) 817.69 Gross Gearing (%) 31.91
Shares in issue (m) 87.95 Debt Ratio 22.73
P/E Ratio 13.76 Debt-to-Equity Ratio 0.63
Total dividends per share (p) 15.40 Assets / Equity Ratio 1.47
Dividend Yield (%) 1.70 Price to book value 3.99
Dividend cover (x) 1.25 ROCE 0.09
Earning per share (p) 67.57 EPS Growth (%) 228.17
52 week high / low 948.50 / 655.00 DPS Growth (%) 10.00

Dechra Pharmaceuticals Director Deals

Dec.Date Type Director Pos No. of Shares
12/09/2014 EXR Ian Page CEO 92,811
12/09/2014 SEXR Ian Page CEO 43,753
03/03/2014 EXR Ian Page CEO 78,656
03/03/2014 SEXR Ian Page CEO 37,080
03/12/2013 EXR Ian Page CEO 5,316

More Dechra Pharmaceuticals Director Deals >>

Dechra Pharmaceuticals Company News

07:00 27/02/2015

Total Voting Rights

/* */ RNS Number : 0047G Dechra Pharmaceuticals PLC 27 February 2015          27 February 2015   Dechra ® Pharmaceuticals PLC (Dechra or the Company)      In conformity with DTR...

09:52 23/02/2015

Dechra Pharmaceuticals underlying operating profits up

Dechra Pharmaceuticals' underlying operating profits rose to £23.1m in the six months to the end of December - 11.7% up at constant exchange rate and 3.6% up at actual exchange rates. Group revenue increased to £100.9m - 11.4% up at constant exchange rates and 5.2% higher at AER). This was...

07:00 23/02/2015

Half Yearly Financial Report 2015

/* */ RNS Number : 5368F Dechra Pharmaceuticals PLC 23 February 2015       Dechra Pharmaceuticals PLC Half-Yearly Financial Report 2015  for the six months ended 31 December 2014   Monday, 23 February 2015 "The Group has...

More Dechra Pharmaceuticals Company News >>

Register now for FREE Dechra Pharmaceuticals company news

Dechra Pharmaceuticals Share Price Discussions

more than 1 year ago

A really dreary share (DPH)

A really dreary share! Dechra Pharmaceuticals manufactures and distributes vetinary products and equiptment.Has a few own brands:- Equipalazone,Vetoryl and Felimazole -anyone used them? My stockbroker molested me so much over this company that I finally bought at 130p,(Feb 04); now at 182.5p...

Register now for FREE Dechra Pharmaceuticals share price discussions